Drug Development for Cancer and Diabetes: A Path to 2030

Drug Development for Cancer and Diabetes: A Path to 2030
Summary
Key features include:
• Details the role of plants for the treatment and management of cancer and diabetes
• Discusses the role of phytocompounds as ligands for cancer and diabetic targets
• Reviews plants and the potential of phytochemicals as antidiabetic and anticancer drugs
• Explores the green biosynthesis of nanoparticles and their treatment efficiency